| NCT05243056 |
A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment |
| NCT04981119 |
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing |
| NCT06092892 |
IIT2023-09-Chung-UpfrontTAD: Upfront TAD/SNB in Patients With Breast Cancer With Nodal Metastases |
| NCT06757192 |
CRC Screening in Unscreened Individuals 45-54 |
| NCT05351424 |
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc |
| NCT06462183 |
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC) |
| NCT07221357 |
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer |
| NCT05417594 |
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies |
| NCT06745895 |
Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening |
| NCT06953245 |
Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy |
| NCT03321045 |
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness |
| NCT01788839 |
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma |
| NCT06130995 |
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer |
| NCT06336928 |
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis |
| NCT04090567 |
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer |
| NCT06551324 |
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). |
| NCT07027488 |
AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT06585488 |
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification |
| NCT07182279 |
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer |
| NCT07341503 |
The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients |
| NCT06654037 |
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer |
| NCT07018869 |
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors |
| NCT04959474 |
Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer |
| NCT05848141 |
Rowing Following Breast Cancer Chemotherapy |
| NCT03408353 |
Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study |
| NCT06051695 |
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression |
| NCT06343077 |
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance |
| NCT07198724 |
ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer |
| NCT06325046 |
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer |
| NCT03127631 |
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients |
| NCT06295159 |
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma |
| NCT07071896 |
A Prospective Study of Video-assisted Exercise Program for the Breast Cancer Survivors |
| NCT07006727 |
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors |
| NCT06954337 |
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial |
| NCT06099769 |
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer |
| NCT03539822 |
Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies |
| NCT05490472 |
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors |
| NCT06158139 |
Autologous CAR-T Cells Targeting B7-H3 in PDAC |
| NCT03866382 |
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors |
| NCT06378346 |
GU-01: Glycyrrhizin in Prostate Cancer |
| NCT05704283 |
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer |
| NCT04511013 |
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases |
| NCT06084013 |
Use Of Indocyanine Green In Pancreas Surgery |
| NCT05056077 |
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) |
| NCT07068477 |
Adaptation of a Values Assessment Tool |
| NCT06101277 |
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG) |
| NCT04402151 |
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer |
| NCT05570253 |
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer |
| NCT02732171 |
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer |
| NCT07228832 |
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer |
| NCT00899626 |
Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients |
| NCT03334708 |
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma |
| NCT06409052 |
Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women |
| NCT06756035 |
CT-95 in Advanced Cancers Associated With Mesothelin Expression |
| NCT07408089 |
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast Cancer |
| NCT02290834 |
Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer |
| NCT07225114 |
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging |
| NCT03513614 |
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS) |
| NCT05037825 |
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors |
| NCT06205316 |
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma |
| NCT06557148 |
A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer |
| NCT05144698 |
RAPA-201 Therapy of Solid Tumors |
| NCT03340506 |
Dabrafenib and/or Trametinib Rollover Study |
| NCT05720338 |
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy? |
| NCT04792463 |
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome |
| NCT04315233 |
Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics |
| NCT07076147 |
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer |
| NCT05896839 |
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer |
| NCT02997709 |
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients |
| NCT05391126 |
GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care |
| NCT04291755 |
Development and Analysis of a Stool Bank for Cancer Patients |
| NCT06633926 |
Integrative Approaches for Cancer Survivorship (IACS3) |
| NCT03823144 |
Intravital Microscopy in Human Solid Tumors |
| NCT06618287 |
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors |
| NCT05581004 |
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT06145633 |
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer |
| NCT06377852 |
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study |
| NCT05826743 |
Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy |
| NCT06215508 |
Geriatric Assessment and Technology Evaluation in Prostate Cancer |
| NCT06826768 |
A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC |
| NCT04427293 |
Preoperative Lenvatinib Plus Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (TNBC) |
| NCT06216249 |
Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) |
| NCT07137468 |
Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk |
| NCT06736717 |
Onvansertib in Combination With NALIRIFOX for First Line Treatment of Advanced Pancreatic Cancer |
| NCT04624555 |
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors |
| NCT06878547 |
VisR Ultrasound for Noninvasively Interrogating Stromal Collagen Organization in Women as a Breast Cancer Biomarker: Evaluation of Anisotropy in Cancer Patients |
| NCT04887935 |
Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer |
| NCT04371913 |
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical Study |
| NCT03809585 |
Observational Study of Iris Tumors |
| NCT05610735 |
Combination Therapy for Recurrent Ovarian Cancer |
| NCT03564340 |
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers |
| NCT06926920 |
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer |
| NCT04005690 |
Targeted Pathway Inhibition in Patients With Pancreatic Cancer |
| NCT06121180 |
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma |
| NCT04697576 |
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma |
| NCT05086250 |
Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer |
| NCT06353997 |
Neoadjuvant INBRX-106 in Combination With Pembrolizumab for Stage II/III TNBC Patients |
| NCT04897321 |
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) |
| NCT02381990 |
MRI/Ultrasound Fusion Guided Prostate Cryotherapy |
| NCT04230109 |
Sacituzumab Govitecan In TNBC |
| NCT07411599 |
Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial") |
| NCT05665738 |
Two-fraction HDR Monotherapy for Localized Prostate Cancer |
| NCT04114136 |
Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies |
| NCT06428409 |
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A) |
| NCT05530655 |
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer |
| NCT07164443 |
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) |
| NCT01205815 |
Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment |
| NCT06946225 |
ACTengine® IMA203 Combined With mRNA-4203 |
| NCT04990921 |
Study of Palliative Radiation Combined with Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer |
| NCT05227326 |
AOH1996 for the Treatment of Refractory Solid Tumors |
| NCT07032584 |
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer |
| NCT04486352 |
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer |
| NCT03054584 |
Genetic Basis of Melanocytic Nevi |
| NCT02328677 |
ColoCare Study - Colorectal Cancer Cohort |
| NCT07368998 |
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer |
| NCT06970847 |
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer |
| NCT05766748 |
Study of Effect of Azeliragon in Patients Refractory to Prior Treatment of Metastatic Pancreatic Cancer |
| NCT05754580 |
High-dose Brachytherapy Boost With Stereostatic Body Radiation Therapy to Intermediate or Higher Risk Prostate Cancer |
| NCT05579366 |
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) |
| NCT05645380 |
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC |
| NCT07225270 |
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy |
| NCT04657068 |
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors |
| NCT02749474 |
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes |
| NCT03686124 |
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors |
| NCT05573126 |
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer |
| NCT06245889 |
PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC |
| NCT05394259 |
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer |
| NCT05784688 |
Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors |
| NCT06437574 |
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer |
| NCT07492927 |
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer |
| NCT06130280 |
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer |
| NCT07383649 |
Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection |
| NCT05805436 |
Preop Laxatives in Robotic Urologic Surgery |
| NCT04423211 |
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging |
| NCT07125209 |
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer |
| NCT06113016 |
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors |
| NCT06040541 |
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT03934905 |
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction |
| NCT07142551 |
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response |
| NCT06827236 |
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer |
| NCT03919292 |
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca |
| NCT06103864 |
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
| NCT07235293 |
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer. |
| NCT02886247 |
Pancreatic Cancer Registry: For Any Person With a Personal or Family History |
| NCT06369259 |
Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer |
| NCT07220512 |
The Better, Harder, Faster, Stronger Study |
| NCT04904757 |
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening |
| NCT05043012 |
Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) |
| NCT04084730 |
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer |
| NCT05877599 |
A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation |
| NCT05438563 |
MRI-guided Transurethral Urethral Ultrasound Ablation for the Treatment of Low to Intermediate Grade Prostate Cancer |
| NCT03909282 |
Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma |
| NCT05384496 |
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma |
| NCT04234386 |
GammaPod Dose Escalation Radiation for Early Stage Breast Cancer |
| NCT06212583 |
High-Risk Metachronous Oligometastatic Prostate Cancer Trial |
| NCT07022483 |
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer |
| NCT05685602 |
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer |
| NCT05248581 |
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases |
| NCT04722692 |
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ |
| NCT06635005 |
A Low-Insulinemic Dietary Intervention to Reduce Breast Cancer Risk in High-Risk Women |
| NCT06465966 |
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning |
| NCT05900895 |
Estradiol Plus Olaparib for Breast Cancer (PHOEBE) |
| NCT06106477 |
Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer |
| NCT04924075 |
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) |
| NCT05056844 |
Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge |
| NCT06638502 |
Safety of HRX215 in Patients After Minor and Major Liver Resection |
| NCT05288777 |
Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer |
| NCT06613100 |
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer |
| NCT02584244 |
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers |
| NCT07121972 |
Mirai-MRI: Validation of AI Models for Breast Cancer Risk |
| NCT05035836 |
A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC) |
| NCT07405801 |
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer |
| NCT06058377 |
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer |
| NCT06849544 |
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection |
| NCT07427043 |
Robotic Opioid-free Prostatectomy Enhanced Strategy (ROPES) |
| NCT07087691 |
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance |
| NCT05676255 |
The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project |
| NCT06425926 |
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors |
| NCT04346225 |
Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer |
| NCT03053193 |
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles |
| NCT06698458 |
Alpha Radiation Emitters Device (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer |
| NCT04868604 |
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE) |
| NCT04633252 |
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer |
| NCT06934538 |
First-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer |
| NCT05241236 |
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer |
| NCT06110793 |
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer |
| NCT05774951 |
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy |
| NCT05691491 |
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness |
| NCT04134260 |
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial |
| NCT06288113 |
Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial |
| NCT05239338 |
Preserving Fertility After Colorectal Cancer Study |
| NCT03096418 |
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response |
| NCT06682650 |
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics) |
| NCT03604315 |
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF |
| NCT05997615 |
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer |
| NCT06691035 |
Immunologic Targeting of ESR1 Receptor for Hormone Receptor Expressing Metastatic Breast Cancer |
| NCT05514717 |
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 |
| NCT03526835 |
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors |
| NCT06529523 |
Tislelizumab in People With Colorectal Cancer |
| NCT06799065 |
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer |
| NCT06940271 |
Feasibility and Effect of Wrapping Nerves With a Multi-Layer Perinatal Tissue Allograft During Prostatectomy |
| NCT06236139 |
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer |
| NCT06690775 |
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. |
| NCT06892275 |
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI |
| NCT04521764 |
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer |
| NCT06545331 |
Study of XB010 in Subjects With Solid Tumors |
| NCT04458532 |
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer |
| NCT06960707 |
Two Versus One Week Breast Radiotherapy (RT) |
| NCT07213609 |
A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid Tumors |
| NCT06710132 |
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) |
| NCT05361174 |
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer |
| NCT04119024 |
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors |
| NCT05071937 |
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer |
| NCT06675357 |
Using FAPI PET/MRI to Evaluate Prostate Cancer |
| NCT05225428 |
Video Education With Result Dependent dIsclosure |
| NCT04282044 |
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies |
| NCT04857502 |
99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer |
| NCT05245812 |
Safety and Feasibility of Robotic SP Nipple Sparing Mastectomy |
| NCT06464107 |
Endometrial Cell Collection With the PadKit |
| NCT07546331 |
Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction |
| NCT05464667 |
Preoperative Irradiation for Stage I Breast Cancer |
| NCT06674811 |
Biomarkers of Resiliency In Childhood Cancer Surgery |
| NCT05334732 |
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters) |
| NCT05542407 |
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer |
| NCT04847063 |
Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies |
| NCT06270706 |
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors |
| NCT07209176 |
Physician- and Patient-based Barriers to NGS Testing |
| NCT05854498 |
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer |
| NCT07118176 |
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers |
| NCT06148298 |
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer |
| NCT07214298 |
Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06531499 |
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study |
| NCT05296421 |
Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer |
| NCT06353321 |
Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 |
| NCT06275126 |
Optimizing Surgical Decisions in Young Adults With Breast Cancer |
| NCT06904378 |
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06774963 |
A Phase 1 Study of LNCB74 in Advanced Solid Tumors |
| NCT06260033 |
Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer |
| NCT06422455 |
Access to Genetic Testing in Underserved Patients With Cancer |
| NCT06938555 |
The RolE of Prolonged Nightly faSTing to Improve Sleep and cOgnition in bREast Cancer Survivors |
| NCT07463599 |
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma |
| NCT07227038 |
Living Well With Advanced Breast Cancer |
| NCT07076485 |
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast Cancer |
| NCT05785741 |
A Study of DB-1310 in Advanced/Metastatic Solid Tumors |
| NCT06512350 |
Identifying Patterns in the Breath of Individuals With Breast Cancer |
| NCT05126290 |
CTNNA1 Familial Expansion Study |
| NCT05969860 |
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer |
| NCT04294927 |
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention |
| NCT06369610 |
Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer |
| NCT06592924 |
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response |
| NCT06937996 |
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System- |
| NCT06620627 |
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection |
| NCT05349227 |
Comprehensive Outcomes for After Cancer Health |
| NCT04752826 |
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) |
| NCT06039085 |
Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment |
| NCT04337580 |
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer |
| NCT06342440 |
Early Detection of Advanced Adenomas and Colorectal Cancer |
| NCT05054413 |
Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method |
| NCT02610413 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer |
| NCT06533059 |
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors |
| NCT06700070 |
A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors |
| NCT06067503 |
Biomarkers to Detect Endocrine Therapy Resistance |
| NCT06815354 |
Comprehensive Assessment of Cancer Theranostic Response |
| NCT06781983 |
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors |
| NCT01521741 |
Prospective Screening for Breast Cancer-related Lymphedema |
| NCT05669430 |
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies |
| NCT07478016 |
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients |
| NCT07067138 |
A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast) |
| NCT00034216 |
Collection of Blood From Patients With Cancer |
| NCT06586047 |
Breast Cancer PSMA PET |
| NCT07416552 |
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC) |
| NCT06148038 |
CBD for Breast Cancer Primary Tumors |
| NCT04503265 |
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies |
| NCT05748834 |
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer |
| NCT07213804 |
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer |
| NCT07307664 |
Increasing Germline Genetic Testing for Patients With Cancer |
| NCT04991948 |
Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer |
| NCT05716893 |
Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer |
| NCT06483048 |
MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer |
| NCT05280314 |
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors |
| NCT07223047 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies |
| NCT05607004 |
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer |
| NCT04590326 |
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab |
| NCT05998135 |
Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer |
| NCT05984589 |
Personalized Health Self-Management Training for Colorectal Cancer Survivors |
| NCT06281678 |
A Study of IBI363 in Subjects with Advanced Solid Malignancies |
| NCT04477343 |
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT02595957 |
Genomic Services Research Program |
| NCT04420702 |
Diffusion Basis Spectrum Imaging of the Prostate |
| NCT03322995 |
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial |
| NCT05659381 |
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer |
| NCT06574880 |
STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer |
| NCT06992258 |
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer |
| NCT06265285 |
Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program |
| NCT06580015 |
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer |
| NCT07300150 |
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors |
| NCT03943316 |
Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies |
| NCT05183126 |
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer |
| NCT03322891 |
Improving Health Literacy in African-American Prostate Cancer Patients |
| NCT05512208 |
A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib |
| NCT04915508 |
Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy |
| NCT06945315 |
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS) |
| NCT06130826 |
Immune Response Activation for the Treatment of Unresectable Metastatic Colorectal Cancer or CEA Positive Metastatic Breast Cancer |
| NCT05974150 |
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring |
| NCT06545604 |
Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer |
| NCT05155033 |
Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma |
| NCT05042687 |
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer |
| NCT05830058 |
Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma |
| NCT06615752 |
Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients |
| NCT06016738 |
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer |
| NCT06995898 |
The Vanguard Study: Testing a New Way to Screen for Cancer |
| NCT05914116 |
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors |
| NCT06600906 |
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer |
| NCT06616155 |
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer |
| NCT07426952 |
Weight Management After Cancer for Survivors in Rural Communities |
| NCT06386887 |
Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer |
| NCT05989347 |
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy |
| NCT07100847 |
Periprostatic Neurolysis in Prostate Cancer |
| NCT06397703 |
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer |
| NCT04150042 |
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells |
| NCT07303894 |
A Study of Isoquercetin in People With Ovarian Cancer |
| NCT06099093 |
Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan |
| NCT03784924 |
EDRN Prostate MRI Biomarker Study |
| NCT06545682 |
Phase Ib Study of AlpeliSib With PEmbroLizumab in Patients With mEtastatic Breast caNcer or melanomA (SELENA) |
| NCT04753879 |
Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cancer. |
| NCT06783179 |
Postoperative Outcomes and Patient Satisfaction With Mayo Clinic Florida Care Hotel After Mastectomy and Tissue Expander Placement |
| NCT04986423 |
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer |
| NCT05077137 |
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy |
| NCT04586959 |
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer |
| NCT05054296 |
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring |
| NCT07080242 |
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors |
| NCT06360354 |
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) |
| NCT05938270 |
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. |
| NCT05625529 |
ExoLuminate Study for Early Detection of Pancreatic Cancer |
| NCT07209436 |
Impact of Pectoral Versus Paravertebral Blocks on Pain and Physical Well-Being in Implant-Based Breast Reconstruction |
| NCT04489238 |
Collection of Information to Better Understand Young Onset Colorectal Cancer |
| NCT06504147 |
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery |
| NCT06798558 |
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy |
| NCT07049055 |
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic Cancer |
| NCT05428007 |
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma |
| NCT05805371 |
PSCA-Targeting CAR-T Cells Plus or Minus Radiation for the Treatment of Patients With PSCA+ Metastatic Castration-Resistant Prostate Cancer |
| NCT06566716 |
A Diagnostic Test to Evaluate Cancer Risk Before Surgery in Women with an Ovarian Mass |
| NCT02610426 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer |
| NCT05376878 |
An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis |
| NCT04995198 |
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness |
| NCT06627244 |
Study of Tebentafusp and Radioembolization in the Treatment of Metastatic Uveal Melanoma |
| NCT04968964 |
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing |
| NCT03484299 |
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma |
| NCT07197554 |
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies |
| NCT06712927 |
Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases |
| NCT07166042 |
Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies |
| NCT05556473 |
F-Tryptophan PET/CT in Human Cancers |
| NCT05134779 |
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You |
| NCT03451383 |
Older Breast Cancer Patients: Risk for Cognitive Decline |
| NCT07155317 |
Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial |
| NCT07216560 |
First-in-human Study of 7MW4911 in GI Cancer |
| NCT04753359 |
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer |
| NCT04464759 |
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma |
| NCT04929223 |
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC) |
| NCT05710380 |
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy |
| NCT06639724 |
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer |
| NCT07067788 |
B.Brilliant Revelation Comparision Study |
| NCT05343013 |
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy |
| NCT06153836 |
Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction |
| NCT02701244 |
A Registry Study of Breast Microseed Treatment |
| NCT07141121 |
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen |
| NCT04003038 |
Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery |
| NCT06466434 |
Prebiotic Food-enriched Diet (PreFED) to Enhance the Microbiome and Response to First-line Immunotherapy in Unresectable Melanoma |
| NCT06504914 |
Preparing FIM-BCS - A Lifestyle Modification for African-American Breast Cancer Survivors |
| NCT05789433 |
Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer |
| NCT02012699 |
Integrated Cancer Repository for Cancer Research |
| NCT06244004 |
FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial |
| NCT06318507 |
The Intestinal Microbiome in Triple Negative Breast Cancer Treated with Immunotherapy |
| NCT07086833 |
The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities |
| NCT07078604 |
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer |
| NCT05254171 |
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer |
| NCT04172532 |
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer |
| NCT05873192 |
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer |
| NCT06385925 |
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation |
| NCT04967976 |
Breast Mesh Used in Two-staged Breast Reconstruction |
| NCT06577987 |
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies |
| NCT05130606 |
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing |
| NCT03878849 |
Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer |
| NCT03495427 |
PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores |
| NCT06972628 |
Treatment of Patients With Progressive mCRPC With 177Lu-PSMA-617 |
| NCT06605430 |
Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer |
| NCT06362369 |
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy |
| NCT03190941 |
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients |
| NCT06634875 |
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) |
| NCT06989112 |
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer |
| NCT06324357 |
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread |
| NCT06557057 |
Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk |
| NCT06194929 |
Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma |
| NCT06435351 |
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy |
| NCT04265872 |
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC |
| NCT07160439 |
Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors |
| NCT06625775 |
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors |
| NCT07285694 |
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC) |
| NCT04329494 |
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer |
| NCT07389967 |
Nutrition Awareness Among Women With Non-Metastatic Breast Cancer |
| NCT05736367 |
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT05684367 |
Exercise to ReGain Stamina and Energy (The EXERGISE Study) |
| NCT05786924 |
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies |
| NCT04221542 |
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT01530373 |
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients |
| NCT07214610 |
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study |
| NCT05497024 |
Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing |
| NCT07324096 |
A Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer |
| NCT02302742 |
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry |
| NCT06052488 |
Strength After Breast Cancer |
| NCT06274047 |
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. |
| NCT01503190 |
The Immune System's Response to Young Women's Breast Cancer |
| NCT06393374 |
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) |
| NCT01042548 |
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum |
| NCT05806515 |
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation |
| NCT07033689 |
Feasibility Study of Suizenji, in Patients With Unresectable Pancreatic Ductal Adenocarcinoma (SUNRISE-II) |
| NCT06060613 |
Safety and Efficacy of OBX-115 in Advanced Solid Tumors |
| NCT06237179 |
Behavioral Exercise Training to Reduce Cardiovascular Disease Risk |
| NCT06157892 |
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors |
| NCT06771544 |
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma |
| NCT07158164 |
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment |
| NCT04030507 |
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer |
| NCT06062498 |
Elacestrant vs Elacestrant Plus a CDK4/6 Inhibitor in Patients With ERpositive/HER2-negative Advanced or Metastatic Breast Cancer |
| NCT06674863 |
Addressing Health Literacy With a Tailored Survivorship Care Plan |
| NCT06971744 |
Autophagy Maintenance (AUTOMAIN) |
| NCT05887609 |
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib |
| NCT06412198 |
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations |
| NCT06820463 |
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer |
| NCT06423963 |
Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer |
| NCT03422198 |
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer |
| NCT05524584 |
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer |
| NCT07153016 |
LEgal Guidance and AdvocaCY for CAREgivers (LEGACY CARE): A Pilot Clinical Trial for Caregivers of Persons With Colorectal Cancer |
| NCT03833921 |
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer |
| NCT04174352 |
FES Imaging to Optimize Tamoxifen for Metastatic Breast Cancer |
| NCT05489211 |
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) |
| NCT07320664 |
Breast Cancer Study Tracking Risk Awareness of Alcohol Consumption and Improving Knowledge in Young Adult Women |
| NCT07335224 |
Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture |
| NCT04945642 |
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma |
| NCT06963905 |
Saci Nivo Rela for TNBC |
| NCT06472661 |
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma |
| NCT05334069 |
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection |
| NCT03463954 |
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors |
| NCT07055854 |
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors |
| NCT06330805 |
Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer |
| NCT02064673 |
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy |
| NCT06522568 |
Testing a Mammography Decision Intervention in a Rural Setting |
| NCT06646627 |
Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors |
| NCT05825482 |
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® |
| NCT05463796 |
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer |
| NCT05454488 |
An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| NCT07164027 |
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial |
| NCT07054723 |
Surviving Daily Life |
| NCT05396872 |
Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer |
| NCT05287451 |
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study |
| NCT04511039 |
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer |
| NCT06728072 |
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer |
| NCT03990896 |
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial |
| NCT05687188 |
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations |
| NCT07278986 |
CYTALUX for Intraoperative Imaging of Patients With Endometrial Cancer |
| NCT06336902 |
Botensilimab Plus Balstilimab and Fasting Mimicking Diet Plus Vitamin C for Patients With KRAS-Mutant Metastatic Colorectal Cancer |
| NCT06398639 |
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer |
| NCT06651632 |
WATER IV Prostate Cancer |
| NCT06624644 |
A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma |
| NCT03935893 |
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers |
| NCT06439693 |
The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer |
| NCT06795009 |
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer |
| NCT04071236 |
Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy |
| NCT07169734 |
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors |
| NCT07158021 |
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial |
| NCT07090499 |
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors |
| NCT05216432 |
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer |
| NCT06551116 |
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer |
| NCT05727904 |
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma. |
| NCT07040891 |
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials |
| NCT07020221 |
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors |
| NCT06394804 |
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer |
| NCT06492616 |
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence |
| NCT06476808 |
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. |
| NCT06044025 |
A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy |
| NCT03678025 |
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer |
| NCT06297525 |
Study of STP938 in Advanced Solid Tumours |
| NCT06423326 |
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer |
| NCT05386108 |
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer |
| NCT07327489 |
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies |
| NCT05913713 |
HIIT Following Breast Cancer Chemotherapy |
| NCT06429813 |
Remotely Monitored Exercise Interventions in Patients with MCSPC Undergoing ADT (Prostate 006) |
| NCT06528990 |
Telehealth Intervention for Ostomy Self-Management |
| NCT06340620 |
EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope |
| NCT06904313 |
Ultralow Dose PET Imaging for PSMA Expression |
| NCT06610539 |
PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients |
| NCT07186296 |
EXoPERT EMERALD Clinical Study |
| NCT07213791 |
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors |
| NCT06172478 |
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors |
| NCT07115043 |
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors |
| NCT05128825 |
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
| NCT04258280 |
Improving Genetic Counseling for BRCA+ Mothers |
| NCT07224789 |
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA |
| NCT06616597 |
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer |
| NCT06411691 |
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer |
| NCT05958082 |
Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer |
| NCT06205836 |
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer |
| NCT02402244 |
Project: Every Child for Younger Patients With Cancer |
| NCT06608511 |
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers |
| NCT05498792 |
Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma |
| NCT04920032 |
Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas |
| NCT05948657 |
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr |
| NCT06399757 |
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors |
| NCT06518057 |
Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer |
| NCT07137871 |
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy |
| NCT06842498 |
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| NCT07040514 |
24GUT540 : Meeting of Breast Cancer Patients and Pathologists |
| NCT04674267 |
Resilience and Equity in Aging, Cancer, and Health (REACH) |
| NCT05812807 |
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab |
| NCT06434064 |
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer |
| NCT04788277 |
Investigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC) |
| NCT06813898 |
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial |
| NCT05187832 |
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer |
| NCT06813053 |
A Novel Patient Decision Aid for Surgical Treatment Options in Early-Stage Breast Cancer |
| NCT07225946 |
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT07043270 |
24BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC |
| NCT05856773 |
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy |
| NCT06178354 |
Focal Ablation With Focal Cryotherapy or HIFU for the Treatment of Men With Localized Prostate Cancer |
| NCT06488365 |
In Vivo Liquid Biopsy of Melanoma (Cytophone) |
| NCT05882253 |
Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial) |
| NCT07102381 |
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer |
| NCT06063928 |
Confronting Cancer as a Community |
| NCT03933670 |
Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance |
| NCT06318273 |
A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate Cancer |
| NCT03701581 |
4-aminopyridine Treatment for Nerve Injury |
| NCT05113537 |
Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer |
| NCT06705686 |
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer |
| NCT06663072 |
Study to Test the Combination of Fulvestrant With Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors |
| NCT05663203 |
A Web-Based Dyadic Intervention for Colorectal Cancer |
| NCT04606446 |
Study of PF-07248144 in Advanced or Metastatic Solid Tumors |
| NCT06689956 |
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study |
| NCT06795529 |
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer |
| NCT07069595 |
PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease |
| NCT07226986 |
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC |
| NCT05208762 |
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors |
| NCT06650579 |
REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial |
| NCT06499870 |
Relugolix and Enzalutamide in Combination With Radiation Therapy for the Treatment of Very High Risk Prostate Cancer, OPTIMAL Trial |
| NCT02838836 |
Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers |
| NCT06144164 |
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer |
| NCT05677802 |
Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer |
| NCT06004245 |
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors |
| NCT06165419 |
Definitive Radiation for High-Risk Spine Metastases |
| NCT06268665 |
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy |
| NCT07543757 |
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix |
| NCT06463028 |
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer |
| NCT07079631 |
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer |
| NCT06989437 |
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue |
| NCT06411795 |
Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy |
| NCT06802172 |
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial |
| NCT06380751 |
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer |
| NCT05611931 |
Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma |
| NCT06845319 |
Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients |
| NCT06648434 |
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06831071 |
Evaluation of Hypoxia in Primary Melanoma |
| NCT05321134 |
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery |
| NCT07192432 |
Gene Therapy for HER-Positive Cancer (SENTRY-HER2) |
| NCT06450106 |
Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy |
| NCT06827704 |
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women |
| NCT07545811 |
Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer |
| NCT06993844 |
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors |
| NCT05809752 |
A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV) |
| NCT03488693 |
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer |
| NCT05726292 |
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer |
| NCT06800313 |
A Study of HLD-0915 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| NCT07122713 |
Definitive Radiation Therapy for Inoperable Breast Cancer |
| NCT06882746 |
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas |
| NCT04766190 |
DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer |
| NCT04611568 |
War on Melanoma™ Public Health & Education Campaign |
| NCT07254091 |
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer |
| NCT06150417 |
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) |
| NCT06046040 |
TmPSMA-02 in mCRPC |
| NCT06553885 |
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC |
| NCT07095517 |
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors |
| NCT06607458 |
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease |
| NCT05603910 |
Phase 1 Clinical Trial of Lenvatinib, Pembrolizumab and Hypofractionated Pelvic Radiation Therapy for pMMR Recurrent/Unresectable Endometrial Carcinoma |
| NCT05803382 |
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers |
| NCT05006131 |
Pancreatic Cancer Screening for At-risk Individuals |
| NCT01950572 |
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma |
| NCT07540572 |
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors |
| NCT06991556 |
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) |
| NCT02960022 |
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
| NCT06559059 |
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs |
| NCT06007690 |
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma |
| NCT06815497 |
Telmisartan in Combination With Cytotoxic Regimens in Platinum-Resistant Ovarian Cancer |
| NCT06173310 |
DCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer |
| NCT07406282 |
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics |
| NCT00912717 |
Pancreatic Adenocarcinoma Gene Environment Risk Study |
| NCT07433660 |
WellSpan-THRIVE Cancer QOL Study |
| NCT06594991 |
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma |
| NCT07229313 |
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors |
| NCT05946213 |
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer |
| NCT07062965 |
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. |
| NCT04115163 |
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer |
| NCT06085664 |
A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy |
| NCT07111507 |
A Study of Tarlatamab for People With Prostate Cancer |
| NCT06355336 |
Real World Prostate Cancer Registry |
| NCT06625034 |
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer |
| NCT07219277 |
Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening |
| NCT06759701 |
Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study |
| NCT06902311 |
Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST) |
| NCT07332000 |
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec |
| NCT07190469 |
PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer |
| NCT05176483 |
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors |
| NCT03802851 |
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer |
| NCT06888102 |
A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer |
| NCT04473833 |
Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer |
| NCT07084168 |
Multimedia Aid for Genetic Testing in Gynecologic Oncology |
| NCT06202183 |
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial |
| NCT05411094 |
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer |
| NCT05253651 |
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer |
| NCT05894239 |
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| NCT04188535 |
Serial MRI Scans During Radiation Therapy |
| NCT05223803 |
TERPS Trial for de Novo Oligometastic Prostate Cancer |
| NCT05045066 |
Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients |
| NCT06867822 |
Trial of ProAgio in Advanced/Metastatic Colorectal Cancer |
| NCT05691010 |
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer |
| NCT07231159 |
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots |
| NCT06738303 |
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer |
| NCT06800105 |
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study |
| NCT04291105 |
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients |
| NCT06773897 |
Rutgers University Study of the Genetics of Breast Cancer. |
| NCT03562273 |
GammaPod Registry and Quality of Life Nomogram |
| NCT06381154 |
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer |
| NCT04725903 |
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate Cancer |
| NCT05484973 |
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss |
| NCT07340541 |
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies |
| NCT07335354 |
A Study of a Decision Tool for People Considering Breast Reconstruction Surgery |
| NCT05111574 |
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery |
| NCT06450873 |
Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery |
| NCT05930483 |
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial |
| NCT06120491 |
Saruparib (AZD5305) vs Placebo in Men With Metastatic Castration-Sensitive Prostate Cancer Receiving Physician's Choice New Hormonal Agents |
| NCT04421820 |
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours |
| NCT05318469 |
Ivermectin in Combination With Balstilimab or Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer |
| NCT03936478 |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
| NCT05076760 |
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors |
| NCT06826924 |
7-Days Water-Only Fasting Trial in Prostate Cancer |
| NCT05305924 |
Fulvestrant+Abemaciclib With Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer |
| NCT05369546 |
Lesion Composition and Quantitative Imaging Analysis on Breast Cancer Diagnosis |
| NCT06276491 |
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors |
| NCT05464082 |
Functional Precision Oncology to Predict, Prevent, and Treat Early Metastatic Recurrence of TNBC |
| NCT04824027 |
Breast Elasticity Imaging During Neoadjuvant Chemotherapy |
| NCT04174742 |
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer |
| NCT07015190 |
Neoadjuvant Darovasertib in Primary Uveal Melanoma |
| NCT03877796 |
Clinical Pre-screening Protocol for Ovarian Cancer |
| NCT06461650 |
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction |
| NCT07293585 |
Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment |
| NCT07436078 |
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors |
| NCT06488378 |
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer |
| NCT06764485 |
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer |
| NCT05056818 |
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics |
| NCT06409390 |
Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer |
| NCT01766297 |
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer |
| NCT07024784 |
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies |
| NCT07197723 |
Study of How People Make Decisions About Prostate Cancer Risk |
| NCT06400550 |
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis |
| NCT05141513 |
Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pancreatic Adenocarcinoma |
| NCT07211659 |
Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients |
| NCT04134780 |
Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer Response |
| NCT06648278 |
Patient Care Outreach, Navigation, Technology and Support 2.0 |
| NCT03947385 |
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions |
| NCT03492424 |
Ablative Therapy in the Management of Prostate Cancer |
| NCT06234423 |
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors |
| NCT06548789 |
Neoadjuvant Immune Checkpoint Blockade + a Prebiotic Food-enriched Dietary Intervention to Optimize Immune Response in Melanoma: NEO-PreFED |
| NCT07186842 |
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9 |
| NCT06059118 |
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer |
| NCT06515613 |
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors |
| NCT06672497 |
Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients |
| NCT06730347 |
A Study of Lorigerlimab in Participants With Advanced Solid Tumors |
| NCT06880055 |
Shield Post-Approval Study Protocol |
| NCT06696768 |
Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Bevacizumab) in Metastatic Colorectal Cancer |
| NCT05683418 |
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer |
| NCT05146297 |
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials |
| NCT06677190 |
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin |
| NCT02926690 |
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer |
| NCT06682390 |
Role of Race in Nutritional Approach in Men on ADT |
| NCT05169970 |
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer |
| NCT06511141 |
Sacral Neuromodulation for Male Overactive Bladder (MOAB) |
| NCT00823654 |
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations |
| NCT06128551 |
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors |
| NCT02253251 |
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment |
| NCT06022029 |
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. |
| NCT06591819 |
Hypofractionated WPPT With HDR Boost |
| NCT04918186 |
Immunotherapy Platform Study in Platinum Resistant High Grade Serous Ovarian Cancer |
| NCT06389786 |
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer |
| NCT04872166 |
A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer |
| NCT07112053 |
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer |
| NCT07396766 |
Dissemination of BREASTChoice AIM1-B |
| NCT03880422 |
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors |
| NCT07198074 |
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer |
| NCT06127979 |
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery |
| NCT06430541 |
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence |
| NCT07244341 |
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC) |
| NCT06997029 |
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors |
| NCT04494945 |
Identifying and Caring for Individuals With Inherited Cancer Syndrome |
| NCT07220239 |
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome |
| NCT06402357 |
High Intensity Focused Ultrasound in Prostate Cancer |
| NCT05372640 |
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors |
| NCT03998202 |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer |
| NCT05053230 |
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer |
| NCT07288359 |
Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors |
| NCT04997096 |
Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy |
| NCT05755269 |
Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women |
| NCT06347705 |
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer |
| NCT07226154 |
Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer |
| NCT06878131 |
Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease |
| NCT04606030 |
LymphBridge: Surgical Evaluation for Breast Cancer-Associated Lymphedema (BioBridge) |
| NCT06079346 |
A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer |
| NCT05546827 |
Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma |
| NCT06085729 |
Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) |
| NCT06751329 |
A Study of DM002 in Patients With Advanced Solid Tumors |
| NCT07317505 |
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors |
| NCT05799274 |
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors |
| NCT06966024 |
Study of DCC-2812 in Participants With Advanced Genitourinary Cancers |
| NCT06831838 |
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors |
| NCT05746897 |
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors |
| NCT07254910 |
Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma |
| NCT05040360 |
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors |
| NCT06959550 |
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer |
| NCT04711824 |
Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases |
| NCT00488878 |
Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors |
| NCT06595160 |
Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy |
| NCT07146568 |
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital |
| NCT04339374 |
Ultrasound and Photoacoustic Imaging for Enhanced Differential Diagnosis of Rectal Cancer |
| NCT02896335 |
Palbociclib and Pembrolizumab In Central Nervous System Metastases |
| NCT05470920 |
Genetic Testing Decision Aid |
| NCT07181161 |
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer |
| NCT05997017 |
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer |
| NCT02871726 |
Transrectal Ultrasound Robot-Assisted Prostate Biopsy |
| NCT07042243 |
The Florida ASCENT Study |
| NCT05703178 |
Web-based Pain Coping Skills Training for Breast Cancer Survivors With AI-Associated Arthralgia |
| NCT06478589 |
Patient Priorities for Survivorship Care in Older Breast Cancer Survivors |
| NCT06568016 |
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers |
| NCT03257033 |
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC |
| NCT05592938 |
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE) |
| NCT06675643 |
Digital Remote Monitoring of Immune Checkpoint Inhibitor Therapy Induced Toxicity Using the Vigilant App |
| NCT06858449 |
Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer |
| NCT06084338 |
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc |
| NCT06332755 |
Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLC |
| NCT04907643 |
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes |
| NCT03646617 |
Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma |
| NCT05698576 |
TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer |
| NCT04333706 |
A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER) |
| NCT05515978 |
Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients |
| NCT05384535 |
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort |
| NCT07519655 |
Phase 1 Study of PF-08046033 in Advanced Solid Tumors |
| NCT05379985 |
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS |
| NCT05519449 |
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) |
| NCT01050504 |
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer |
| NCT06942104 |
Imaging of Solid Tumors Using 18F-TRX |
| NCT05646316 |
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer |
| NCT03769766 |
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance |
| NCT05926102 |
The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) |
| NCT07125729 |
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients |
| NCT07093177 |
Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer |
| NCT03808337 |
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease |
| NCT07222267 |
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors |
| NCT06824467 |
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103) |
| NCT03941756 |
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma |
| NCT07470853 |
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors. |
| NCT04701645 |
Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer |
| NCT07114939 |
FTT PET/CT in Pancreatic Neuroendocrine Tumors |
| NCT07319871 |
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer |
| NCT04563507 |
Combined Immunotherapies in Metastatic ER+ Breast Cancer |
| NCT04765150 |
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification |
| NCT04475640 |
Cancer Genetic Testing in Ethnic Populations |
| NCT07476001 |
Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC |
| NCT02610439 |
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer |
| NCT07206056 |
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) |
| NCT07173257 |
PROMs After Pancreatectomy |
| NCT04489719 |
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer |
| NCT04739072 |
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study |
| NCT06134375 |
A Study of Tetrathiomolybdate (TM) Plus Capecitabine |
| NCT06638307 |
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer |
| NCT06677112 |
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer |
| NCT06365619 |
Neoadjuvant Ipilimumab/Nivolumab for Patients With Recurrent, High Risk, Resectable Melanoma |
| NCT06736054 |
A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer |
| NCT05327465 |
Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy |
| NCT04683653 |
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer |
| NCT03572374 |
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job |
| NCT07216105 |
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors |
| NCT05779423 |
Cryoablation+Ipilimumab+Nivolumab in Melanoma |
| NCT05984888 |
Pilot Study of a MIND Diet Intervention in Women Undergoing Active Treatment for Breast Cancer |
| NCT04650256 |
Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences |
| NCT07313241 |
Phase II Trial of PSA Response-based Androgen Deprivation Therapy and Nodal Coverage for Prostate Cancer Early Salvage Radiotherapy (RANGER) |
| NCT04887805 |
Lenvatinib and Pembrolizumab Maintenance Therapy for the Treatment of Patients of Advanced Unresectable Pancreatic Cancer |
| NCT07322094 |
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer |
| NCT05932862 |
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors |
| NCT05174286 |
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk |
| NCT01000883 |
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior |
| NCT04473794 |
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts |
| NCT05238922 |
Study of INCB123667 in Subjects With Advanced Solid Tumors |
| NCT04553770 |
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer |
| NCT06242470 |
A Study of MGC026 in Participants With Advanced Solid Tumors |
| NCT01776905 |
In Vivo Real-time Detection of Circulating Melanoma Cells |
| NCT05058846 |
Pilot Study of Pancreatic Cancer Screening |
| NCT06096688 |
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction |
| NCT04878094 |
A Study of Intra-operative Imaging in Women With Ovarian Cancer |
| NCT06940739 |
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel |
| NCT07288112 |
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma |
| NCT07522073 |
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma |
| NCT06804785 |
Hybrid Intelligence for Trustable Diagnosis and Patient Management of Prostate Cancer (HIT-PIRADS) |
| NCT06441890 |
BRE-10: Biomarker Optimization of Neoadjuvant Therapy in Breast Cancer |
| NCT05704842 |
Evaluate Impact of Exercise Program on Fatigue in Breast Cancer During Chemotherapy |
| NCT06492070 |
Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers |
| NCT05804370 |
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) |
| NCT07237269 |
Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer |
| NCT06660420 |
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel) |
| NCT06896474 |
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers |
| NCT06115486 |
EXERT-BCH Exercise Regimen to Improve Muscle Mass After Treatment of Breast Cancer |
| NCT05911243 |
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer |
| NCT04969835 |
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours |
| NCT06040125 |
Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial |
| NCT04585750 |
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) |
| NCT05190978 |
Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction |
| NCT06318897 |
Open-label, Single Center, Single-arm, Phase 2 Study of Neoadjuvant Pembrolizumab in Combination With Carboplatin and Paclitaxel in Patients With Stage 1 cT1b-T1cN0M0 Triple Negative Breast Cancer |
| NCT05447923 |
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities |
| NCT06915168 |
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer |
| NCT06179160 |
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation |
| NCT06264180 |
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3] |
| NCT06500455 |
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain |
| NCT05624918 |
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma |
| NCT06579417 |
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer |
| NCT07064018 |
Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies |
| NCT07115914 |
PSMA PET for Surveillance After Focal Therapy |
| NCT06985238 |
Stratagen Quantitative Prostate MRI Platform Pilot Study |
| NCT04975217 |
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer |
| NCT06876714 |
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab |
| NCT06414733 |
HER-2 B Cell Peptide Vaccine |
| NCT06023576 |
A Study of Blood Pressure Control During Cancer Treatment |
| NCT05356117 |
Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial |
| NCT03824652 |
WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy |
| NCT06533826 |
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd |
| NCT07208084 |
Project SOAR (Speaking Our African American Realities) Awakenings for Black American Women Diagnosed With Breast Cancer |
| NCT00040352 |
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma |
| NCT06534125 |
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer |
| NCT07285993 |
Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET |
| NCT06105749 |
Biennial CEM in Women With a Personal History of Breast Cancer |
| NCT06305247 |
A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours |
| NCT06764940 |
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases |
| NCT05696626 |
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation |
| NCT07271017 |
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe |
| NCT02021604 |
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma |
| NCT05983276 |
Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer |
| NCT04370587 |
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
| NCT04797039 |
MRI-Guided Cryoablation for Focal Native Prostate Cancer |
| NCT03860883 |
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma |
| NCT06954831 |
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer |
| NCT06172283 |
Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy |
| NCT06697301 |
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. |
| NCT07189195 |
TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma |
| NCT02861573 |
Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) |
| NCT03460769 |
Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) |
| NCT03796559 |
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes |
| NCT05549297 |
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) |
| NCT07046923 |
A Study of LY4175408 in Participants With Advanced Cancer |
| NCT05561842 |
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries) |
| NCT07103018 |
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001) |
| NCT06085313 |
Cancer Pain Management Using a Web-based Intervention |
| NCT06284590 |
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients |
| NCT06564571 |
Artificial Intelligence in Endoscopic Ultrasound |
| NCT06199713 |
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients |
| NCT06534918 |
Precise Oncology Interventions in Nutrition and Training (OnPoint) |
| NCT05458674 |
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC |
| NCT03785288 |
Vaginal Cuff Brachytherapy Fractionation Study |
| NCT06885697 |
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma |
| NCT07029490 |
Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study |
| NCT03821246 |
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy |
| NCT06030622 |
Phase 2A Pilot C3 Trial of Recurrent/Refractory Metastatic Advanced Pancreatic Cancer |
| NCT06841354 |
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011) |
| NCT06833866 |
Phase I Trial of 5-Fluorouracil (5FU) -Based Therapy in Combination With Hydroxytyrosol (HT) in Patients With Advanced or Metastatic Colorectal Cancer |
| NCT05223322 |
Understanding and Addressing Disparities in Cancer Therapy Induced Inflammation and Associated Endothelial Dysfunction |
| NCT06635980 |
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer |
| NCT07318805 |
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors |
| NCT06897488 |
EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial |
| NCT06105684 |
Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer |
| NCT07306559 |
A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) |
| NCT04751396 |
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors |
| NCT03011684 |
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial |
| NCT07202247 |
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial |
| NCT04641247 |
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study |
| NCT06931340 |
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial |
| NCT06998940 |
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations |
| NCT07145255 |
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors |
| NCT05679674 |
Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer |
| NCT04074135 |
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors |
| NCT06184750 |
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial |
| NCT06586515 |
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors |
| NCT07287917 |
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors |
| NCT06751589 |
A Study of a Weight Loss Intervention in People With Endometrial Cancer |
| NCT07227168 |
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer |
| NCT06492759 |
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer |
| NCT07238023 |
Promoting Active Living Among People With Metastatic Breast Cancer |
| NCT06805825 |
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit |
| NCT05483491 |
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer |
| NCT06817226 |
BREAST Choice Decision Tool R21 - AIM2 |
| NCT06953089 |
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors |
| NCT06572410 |
Prospective Analysis of EnVisio Spatial Intelligence for Soft Tissue Localization and Guided Surgical Excision |
| NCT06413680 |
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body |
| NCT04778449 |
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma |
| NCT04588025 |
Disposable Perfusion Phantom for Accurate DCE (Dynamic Contrast Enhanced)-MRI Measurement of Pancreatic Cancer Therapy Response |
| NCT03729115 |
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer |
| NCT06867484 |
Breast Re-irradiation After Second Ipsilateral Lumpectomy |
| NCT04318717 |
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma |
| NCT05590624 |
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer |
| NCT05959291 |
Discontinuation of Maintenance HER-2 Directed Therapy in Long-Term Survivors of Metastatic HER-2 Positive Breast Cancer |
| NCT03536897 |
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry |
| NCT04692818 |
3D Ultrasound Breast Imaging |
| NCT05620329 |
UNC Pleural Fluid Registry |
| NCT07054346 |
Comparison of 177Lu-PSMA-617 and 225Ac-PSMA-617 |
| NCT05496829 |
IMPACT Trial: Intervention to iMProve AdherenCe Equitably |
| NCT05903131 |
Uterine Preservation Via Lifestyle Transformation |
| NCT05899361 |
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest |
| NCT06435429 |
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer |
| NCT03175224 |
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors |
| NCT05649072 |
Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics. |
| NCT07227077 |
Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial |
| NCT00843375 |
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas |
| NCT07016399 |
Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC |
| NCT06408298 |
HCQ in Resectable Localized Prostate Cancer |
| NCT07100106 |
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer |
| NCT06138067 |
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients |
| NCT04468061 |
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC |
| NCT06173362 |
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer |
| NCT06518837 |
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer |
| NCT04572451 |
Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma |
| NCT03608631 |
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation |
| NCT05806931 |
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer |
| NCT06496256 |
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial |
| NCT04573231 |
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer |
| NCT06165302 |
Exercise in Prostate Cancer |
| NCT04693377 |
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial |
| NCT04812366 |
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer |
| NCT06384222 |
Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone |
| NCT06523777 |
PRISM: Patient Experiences With PET Imaging in Prostate Cancer |
| NCT07173751 |
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer |
| NCT06136624 |
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) |
| NCT06864754 |
WashU DIEP Flap Video and Patient Understanding Improvement |
| NCT06123286 |
Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms |
| NCT05129605 |
Prostate Cancer Genetic Risk Evaluation and Screening Study |
| NCT06923527 |
Circulating Tumor DNA |
| NCT07318051 |
Sample Collection for Ongoing Research and Product Evaluation Study |
| NCT06953882 |
Impact of Omitting Chemo Based on Patient's Selection for ER-Positive, HER2-Negative Breast Cancer With Ribociclib and Endocrine Therapy |
| NCT06545045 |
Cognitive Rehabilitation Following Breast Cancer Treatment |
| NCT06067295 |
Longitudinal Advanced Prostate Cancer Cohort (LAPCC) |
| NCT06149481 |
Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC) |
| NCT04903119 |
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma |
| NCT06247995 |
A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor. |
| NCT07234981 |
PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer |
| NCT07147231 |
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer |
| NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
| NCT04275557 |
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas |
| NCT07173101 |
Clinical Investigation of the Effects of Semiconductor Embedded Therapeutic Garments on Cancer-related Cognitive Impairment in Breast and Gynecological Cancer Patients |
| NCT06358430 |
Dose Escalation and Expansion Study of TROP2 CAR Engineered IL-15- Transduced Cord Blood-derived NK Cells in Combination With Cetuximab in Patient With Colorectal Cancer (CRC) With Minimal Residual Disease (MRD) |
| NCT06998407 |
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors |
| NCT06598007 |
A Study to Determine the Effect of CT3001 in Patients with Advanced Solid Tumors |
| NCT07220967 |
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement |
| NCT05588128 |
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL |
| NCT06305598 |
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer |
| NCT07023887 |
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning |
| NCT07096999 |
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy |
| NCT05365581 |
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer |
| NCT04541381 |
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care |
| NCT02674100 |
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry |
| NCT05977036 |
BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer |
| NCT00353483 |
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells |
| NCT06638294 |
Study in Patients With Breast Cancer Leptomeningeal Metastasis |
| NCT05355701 |
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations. |
| NCT05155501 |
Clinical Trial of Approaches to Prostate Cancer Surgery |
| NCT05933265 |
Study of LP-184 in Patients With Advanced Solid Tumors |
| NCT05128890 |
Evaluation of Resection Techniques for Pancreatic Tumors |
| NCT06958328 |
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer |
| NCT07285057 |
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance |
| NCT07042581 |
A Study of Revaree Plus in People With Breast Cancer |
| NCT03723928 |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
| NCT05705401 |
Testing Radiation and HER2-targeted Therapy Versus HER2-targeted Therapy Alone for Low-risk HER2-positive Breast Cancer |
| NCT06589440 |
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) |
| NCT07405476 |
Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment |
| NCT06881992 |
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism |
| NCT07483307 |
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer |
| NCT06469281 |
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers |
| NCT06507930 |
The COMPASSION Study |
| NCT05607095 |
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma |
| NCT03972657 |
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors |
| NCT03805919 |
Men at High Genetic Risk for Prostate Cancer |
| NCT04774419 |
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery |
| NCT06526819 |
SMP-3124LP in Adults With Advanced Solid Tumors |
| NCT05923684 |
NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making |
| NCT03906253 |
Effectiveness of Fractionated Laser Resurfacing to Protect Geriatric Skin From Actinic Neoplasia |
| NCT05922930 |
Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer |
| NCT05269381 |
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors |
| NCT05705492 |
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer |
| NCT03671044 |
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients |
| NCT06139107 |
RADIANT: Pre-op Radiation With Abemaciclib and Letrozole |
| NCT05942300 |
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer |
| NCT04646434 |
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy |
| NCT04858334 |
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation |
